Angiogenesis Driven by the CEBPD-hsa-miR-429-VEGFA Signaling Axis Promotes Urothelial Carcinoma Progression.
Ti-Chun ChanChung-Hsi HsingYow-Ling ShiueSteven K HuangKun-Lin HsiehYu-Hsuan KuoChien-Feng LiPublished in: Cells (2022)
We decipher the oncogenic mechanism of CEBPD on angiogenesis through the hsa-miR-429 inhibition to stabilize the expression of VEGFA in UC. The novel research unveiled the modulation of the CEBPD/hsa-miR-429/VEGFA axis on the progression of UC and could be accessible to theranostic biomarkers.